Delivery Order SPE2DR25D2104-SPE2DR26F3PZN
Award Date 11/26/25
Potential Completion Date 12/18/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,352.24 to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units). This competitively awarded, firm fixed price delivery order is scheduled for completion by September 4, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a movement disorder associated with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a...
- The Defense Logistics Agency awarded a delivery order valued at $3,676.12 to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units) under a firm fixed-price contract. This non-set-aside award was issued on August 18, 2025, with an ultimate completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. INGREZZA is a branded antipsychotic medication used to treat tardive dyskinesia, a neurological movement...
- The Defense Logistics Agency awarded a delivery order valued at $14.7K to AmerisourceBergen Drug Corp for INGREZZA 40 mg capsules (30-count units) on September 17, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of tardive dyskinesia, a neurological movement disorder,...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 mg capsules (30-count) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price delivery order represents a non-competitive set-aside and will be performed at the contractor's location in Conshohocken, Pennsylvania. INGREZZA is a neurological medication used to treat tardive dyskinesia, a movement disorder associated with...
- The Defense Logistics Agency awarded a $3,874.06 firm fixed price delivery order to AmerisourceBergen Drug Corp for INGREZZA 40 mg capsules (30-count) on November 14, 2025, with completion scheduled for December 8, 2025. This non-compete award will be fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat involuntary movement disorders associated with antipsychotic medications, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INGREZZA 80 MG capsules (30-count supply) valued at $4,027.70 under a firm fixed price contract. The award was made on September 11, 2025, with an ultimate completion date of October 2, 2025. This is a non-set-aside competitive award executed as a delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INGREZZA 60 mg capsules (30-count) on November 20, 2025, with a ceiling value of $4,267.66 and firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of December 12, 2025, to be performed at the awardee's corporate office in Conshohocken, Pennsylvania. INGREZZA is a prescription antipsychotic medication used to treat involuntary movement disorders associated with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 capsules of INGREZZA 40 mg, a medication used to treat tardive dyskinesia in patients with schizophrenia or bipolar disorder. This firm fixed price delivery order, valued at $15,056.06, was competitively awarded without set-aside provisions and is scheduled for completion by August 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $4,267.66 to AmerisourceBergen Drug Corp for the supply of INGREZZA 60 mg capsules (30-count units) on December 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract's ultimate completion date is December 31, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...